CymaBay Therapeutics, Inc.
CBAY
Hisse Senetlerindeki Sıralama
#5774
CymaBay Therapeutics, Inc. is a biopharmaceutical company in the clinical... CymaBay Therapeutics, Inc. is a biopharmaceutical company in the clinical development phase, focused on discovering and delivering treatments for liver disorders and various other long-term illnesses. A key experimental therapy in their portfolio is seladelpar (MBX-8025), a selective activator of the peroxisome proliferator activated receptor delta. This compound is currently undergoing a pivotal Phase III clinical trial for primary biliary cholangitis (PBC), and has also concluded a Phase 2b study investigating its use for nonalcoholic steatohepatitis (NASH). Additionally, the company is advancing MBX-2982 through Phase 2a clinical trials, aiming to address hypoglycemia in individuals with type 1 diabetes. CymaBay maintains strategic partnerships, including a licensing arrangement with ABW Cyclops SPV LP to aid the development of seladelpar for PBC. They also possess a global license from Janssen Pharmaceuticals, Inc. to research, develop, and bring to market compounds active against an undisclosed metabolic disease target. Established in 1988 and formerly known as Metabolex, Inc., CymaBay Therapeutics, Inc. is headquartered in Newark, California.
Hisse Fiyatı
$32.48
Son senkronizasyon: 2024-03-25
Piyasa Değeri
$2.24B
Değişim (1 gün)
0.00%
Değişim (1 yıl)
-0.01%
Ülke
US
Ticaret CymaBay Therapeutics, Inc. (CBAY)
Kategori
Healthcare
CymaBay Therapeutics, Inc. (CBAY) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $32.38 - 2024-03-01
Gün sonu en düşük fiyat: $11.69 - 2018-01-01
Gün sonu en düşük fiyat: $11.69 - 2018-01-01
CymaBay Therapeutics, Inc. için hisse fiyatı geçmişi: 2018 - 2026
Yıllık Hisse Fiyatı Performansı
| Yıl | Performans |
|---|---|
| 2024 | 49.45% |
| 2023 | 354.32% |
| 2022 | 40.76% |
| 2021 | -44.18% |
| 2019 | -15.64% |
| 2018 | 0.00% |
Benzer şirketler veya rakiplerin hisse fiyatı
| Şirket | Hisse fiyatı | Değişim 1yıl% | Ülke |
|---|---|---|---|
| $536.36 | 25.78% |
US
|
|
| $231.06 | 760.55% |
US
|
|
| $137.83 | -3.78% |
AU
|
|
| $879.87 | 8.07% |
NL
|
|
| $291.76 | 2.51% |
BE
|
